Veterinary Medicines

Calcitat 25, solution for infusion and injection in cattle

Authorised
  • Calcium gluconate monohydrate
  • Calcium borogluconate
  • Calcium hydroxide
  • Magnesium chloride hexahydrate
Download as PDF

Product identification

Medicine name:
Calcitat 25, solution for infusion and injection in cattle
Active substance:
  • Calcium gluconate monohydrate
  • Calcium borogluconate
  • Calcium hydroxide
  • Magnesium chloride hexahydrate
Target species:
  • Cattle
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Calcium gluconate monohydrate
    1.55
    gram(s)
    /
    100.00
    millilitre(s)
  • Calcium borogluconate
    21.45
    gram(s)
    /
    100.00
    millilitre(s)
  • Calcium hydroxide
    0.66
    gram(s)
    /
    100.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    3.25
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection/infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AA
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • 1 500 ml bottle.Vial: Sterile plastic bottle (Type PP28).Stopper: Chlorobutyl rubber stopper.Cap: Aluminium cap.
  • 250 ml.Vial: Sterile plastic bottle (Type PP28).Stopper: Chlorobutyl rubber stopper.Cap: Aluminium cap.
  • 20 500 ml bottlesVial: Sterile plastic bottle (Type PP28).Stopper: Chlorobutyl rubber stopper.Cap: Aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pasteur Filiala Filipesti S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10826/001/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."